ArticleOncology letters2025

Alectinib efficacy in advanced lung adenocarcinoma with coexistence of a novel ALK-MTUS2 and STRN3-ALK double fusion: A case report and literature review.

Xirui Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.